| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/27/2004 | US20040102473 Cardiovascular disorders |
| 05/27/2004 | US20040102472 Method of preparing inhibitors of phosphodiesterase-4 |
| 05/27/2004 | US20040102471 Viricides; anticancer agents |
| 05/27/2004 | US20040102470 Using tiotropium compound |
| 05/27/2004 | US20040102469 Method for reducing the mortality rate |
| 05/27/2004 | US20040102468 Controlling discharge of urine |
| 05/27/2004 | US20040102467 Antiinflammatory agents; central nervous system disorders; antiproliferative agents |
| 05/27/2004 | US20040102466 Analgesics; antipyretics; antiinflammatory agents |
| 05/27/2004 | US20040102464 Hypotensive agents; cardiovascular disorders; anticancer agents; headaches; antihistamines; antiinflamamtory agents |
| 05/27/2004 | US20040102462 Viricides; bioavailability; 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy3-hydroxy-1-propanyl-L-valinate in diastereoisomer form |
| 05/27/2004 | US20040102461 Synergistic mixture with anticancer drugs |
| 05/27/2004 | US20040102460 Phosphodiesterase 4 inhibitors |
| 05/27/2004 | US20040102459 Central nervous system disorders; Parkinson's disease; antidepressants |
| 05/27/2004 | US20040102458 Antiproliferative agents; antitumor agents; binding to chaperone protein |
| 05/27/2004 | US20040102456 Aids therapy; viricides |
| 05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
| 05/27/2004 | US20040102454 Anticancer agents; fungicides |
| 05/27/2004 | US20040102453 Antiproliferative agents |
| 05/27/2004 | US20040102450 Substituted oxoazaheterocyclyl compounds |
| 05/27/2004 | US20040102448 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 05/27/2004 | US20040102447 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 05/27/2004 | US20040102445 Synergistic mixture; hypotensive agents for eyes |
| 05/27/2004 | US20040102444 Method for delivering drugs to the retina |
| 05/27/2004 | US20040102442 Central nervous system disorders; brain disorders |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040102440 Method of promoting smoking cessation |
| 05/27/2004 | US20040102439 Halogenobenzyl aminopropionic acid derivatives |
| 05/27/2004 | US20040102438 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 05/27/2004 | US20040102436 Heterocyclic compound derivatives and medicines |
| 05/27/2004 | US20040102435 Alzheimer's disease; psychological disorders; anxiolytic agents; antidepressants; hormone replacement therapy |
| 05/27/2004 | US20040102434 Method for treating pain with loxapine and amoxapine |
| 05/27/2004 | US20040102432 Asthma, rhinitis therapy |
| 05/27/2004 | US20040102431 Protease inhibitors |
| 05/27/2004 | US20040102429 Zinc salt compositions for the prevention of dermal and mucosal irritation |
| 05/27/2004 | US20040102428 Chemokine receptor binding heterocyclic compounds |
| 05/27/2004 | US20040102427 Estrogen beta receptor agonists to prevent or reduce the severity of cardiovascular disease |
| 05/27/2004 | US20040102426 16,17-carbocyclic condensed steroid compounds having selective estrogenic activity |
| 05/27/2004 | US20040102424 Hypotensive agents; cardiovascular diosrders |
| 05/27/2004 | US20040102423 Spironolactone and angiotensin II antagonist combination therapy for treatment of congestive heart failure |
| 05/27/2004 | US20040102422 Administering human papillomaviruse protein; urogenital cancer therapy |
| 05/27/2004 | US20040102421 Tocopherol and tocotrienol anti-inflammatory medicaments |
| 05/27/2004 | US20040102420 Primary N-hydroxylamines |
| 05/27/2004 | US20040102419 Use of creatine or creatine analogs for the treatment of diseases of the nervous system |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102417 Reaction product of carborane and vitamin d; therapy for vitamin deficiency diseases |
| 05/27/2004 | US20040102416 Antiallergic composition |
| 05/27/2004 | US20040102415 Diffusion of aqueous brine solution containing antioxidant and arginine; fluid flow circuits |
| 05/27/2004 | US20040102414 Methods and compositions for treating flaviviruses and pestiviruses |
| 05/27/2004 | US20040102411 DNA vaccine against feline immunodeficiency virus |
| 05/27/2004 | US20040102408 Method and medicament for inhibiting the expression of a given gene |
| 05/27/2004 | US20040102387 Neutralizing agent for clostridium bacterial neurotoxins and preparation method thereof |
| 05/27/2004 | US20040102386 Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto |
| 05/27/2004 | US20040102385 Tocopherol and tocotrienol anti-obesity medicaments |
| 05/27/2004 | US20040102383 Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy |
| 05/27/2004 | US20040102379 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 05/27/2004 | US20040102376 Use of rgm and its modulators |
| 05/27/2004 | US20040102358 Composition for treating skin conditions |
| 05/27/2004 | US20040101935 Obtaining fibers, beta-glucan starches, proteins and ethanol solubles from plant flour using ethanol and water |
| 05/27/2004 | US20040101934 Beverage comprising peptide nerve growth factor conjugate for use in treatment of pain; analgesics; tranquilizers |
| 05/27/2004 | US20040101931 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 05/27/2004 | US20040101927 Comprises nucleotide sequences coding polypeptides for diagnosis, prognosis, prevention and treatment of neurodegenerative and cancer disorders |
| 05/27/2004 | US20040101902 Contacting an agent with a cell-free system which contains PPAR-gamma, permits the expression of early growth response gene-1 and inhibits such expression in presence of PPAR-gamma agonist, stimulating cell free system to increase Egr-1 |
| 05/27/2004 | US20040101865 Comprises nucleotide sequences coding polypeptides associated with biosynthesis and metabolism of acetyl-CoA for preparing food, feed, cosmetics and pharmaceutical agents |
| 05/27/2004 | US20040101853 Modulation of STAT2 expression |
| 05/27/2004 | US20040101837 Nucleotide sequences coding for proteins involved in the biosynthesis of L-serine, an improved method for the microbial production of L-serine and a genetically modified microorganism suitable therefor |
| 05/27/2004 | US20040101821 Antiviral antisense therapy |
| 05/27/2004 | US20040101595 Vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, vitamin C, caffeine, quercetin, epigallocatechin gallate, epicatechin, epicatechin gallate, epigallocatechin, and polypheron E. |
| 05/27/2004 | US20040101584 Control of cancer with annonaceous extracts |
| 05/27/2004 | US20040101582 Ketamine, gabapentin and clonidine |
| 05/27/2004 | US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer |
| 05/27/2004 | US20040101577 Composition for treating acne vulgaris and fabrication method |
| 05/27/2004 | US20040101575 Comprehensive pharmacologic therapy for treatment of obesity |
| 05/27/2004 | US20040101574 Antitumor |
| 05/27/2004 | US20040101568 Microgranules based on active principle and method for making same |
| 05/27/2004 | US20040101567 Granular preparations for oral administration |
| 05/27/2004 | US20040101565 Mehtod to obtain microparticles containing a h+ k+ atp-ase inhibitor |
| 05/27/2004 | US20040101564 Embolization |
| 05/27/2004 | US20040101561 Combinations of viscoelastics for use during surgery |
| 05/27/2004 | US20040101560 Methods and compositions for applying pharmacologic agents to the ear |
| 05/27/2004 | US20040101558 Drug with enteric coating; oral administering |
| 05/27/2004 | US20040101556 Stable pharmaceutical compositions without a stabilizer |
| 05/27/2004 | US20040101555 Stabilization by mixing with desiccant; encapsulated in polymer; dietetics; appeptite suppressants |
| 05/27/2004 | US20040101554 Fatty acid in soft gelatin capsule; plant and animal extracts; controlling taste |
| 05/27/2004 | US20040101551 Transdermal therapeutic system for releasing venlafaxine |
| 05/27/2004 | US20040101550 Transdermal therapeutic system |
| 05/27/2004 | US20040101549 Transdermal administering estrogen |
| 05/27/2004 | US20040101544 Method for detoxifying a carbohydrate containing solution |
| 05/27/2004 | US20040101543 Solid matrix; transmucosal mouth administering; sustained release form |
| 05/27/2004 | US20040101542 Side effect reduction; topical applying; antiaging agents; mixture of retinoid compound with liposome |
| 05/27/2004 | US20040101538 Synergistic mixture of terbinafine with diclofenac or indomethacin; fungicide |
| 05/27/2004 | US20040101535 Administering nucleoside, or prodrug thereof; viricides |
| 05/27/2004 | US20040101529 Regulation of human serine-threonine protein kinase |
| 05/27/2004 | US20040101521 Reducing concentration of iron in animal tissue by complexing, chelation |
| 05/27/2004 | US20040101515 Gel-based cosmetic and wound-healing formulation and method |
| 05/27/2004 | US20040101506 Composition for the prevention and treatment of inflammation of the ear |
| 05/27/2004 | US20040101487 Combinations of formoterol and fluticasone propionate for asthma |
| 05/27/2004 | US20040101486 Budesonide for diseases of nose, respiratory system disorders |
| 05/27/2004 | US20040101485 Kidney and liver diseases; antiarthritic agents; antidepressants; Alzheimer's disease; Parkinson's disease; cardiovascular disorders; anticancer agents |
| 05/27/2004 | US20040101484 Nasal delivery of apomorphine in combination with glycol derivatives |
| 05/27/2004 | US20040101483 Mixture of drug with aerosol propellant; supplying lungs |